Brief Summary

To describe the current treatment practice during 12 months for previously treated patients diagnosed with haemophilia A or haemophilia B.

Trial Health

On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment

1,658

participants targeted

Target at P75+ for all trials

Timeline

Completed

Started Mar 2014

Geographic Reach

7 countries

12 active sites

Status

completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

1.5 years study duration

First Submitted

Initial submission to the registry

January 28, 2014

Completed

1 day until next milestone

First Posted

Study publicly available on registry

January 29, 2014

Completed

1 month until next milestone

Study Start

First participant enrolled

March 1, 2014

Completed

1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed

Last Updated

March 14, 2016

Status Verified

March 1, 2016

Enrollment Period

1.5 years

First QC Date

January 28, 2014

Last Update Submit

March 11, 2016

Conditions

Haemophilia A Haemophilia B

Outcome Measures

Primary Outcomes (2)

Total dose (IU) issued of Factor VIII during a 12 month period
- 12 month to Day 0
Total dose (IU) issued of Factor IX during a 12 month period
- 12 month to Day 0

Eligibility Criteria

Age2 Years+

Sexmale

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

The study population consists of patients with a diagnosis of ICD10: haemophilia A D66.9 or haemophilia B D67.9.

You may qualify if:

Male patients with severe or moderate haemophilia A or haemophilia B.
Informed consent is obtained from the patient or patient's legal representative (as applicable according to legal regulation).

You may not qualify if:

Confirmed positive inhibitor test detected in the past 24 months.

Contact the study team to confirm eligibility.